4Marbeuf Gueye C, Salerno M, Quidu P, et al. Inhibition of the Pglycoprotein and multidrug resistance protein - mediated efflux of anthracyclines and calceina cetoxymethyl ester by PAK-104P[J]. Eur J Pharmacol, 2000,391(3):207-216.
5Motoji T, Motomura S, Wang YH. Multidrug resistance of acute leukemia and a strategy to overcome it[J].Int J Hematol, 2000, 72(4):418-424.
6Swannie HC, Kaye SB. Protein kinase C inhibitors[J]. Curr Oncol Rep, 2002, 4(1):37-46.
7Komuro Y, Udagawa Y, Susumu N, et al. Paclitaxel and SN-38 overcome cisplatin resistance of cell lines by down - regulating the influx and efflux system of cispaltin[J]. Cancer Res, 2001,92(11):1242-1250.
8Poirson Biochat F, Concalves RA, Miceoli L, et al. The expression of drug resistance gene products during the progression of human prostate cancer[J]. Clin Cancer Res, 2000,6(2):643-653.
9Mistry P, Stewart AJ, Dangerfield W, et al. In vitro and in vivo characterization of XRl1576, a novel, orally active, dual inhibitor of topoisomeraseⅠand Ⅱ[J]. Anticancer Drugs, 2002, 13(1):15-28.
10Pophilic camptothecin BUP1350 is an effective drug in experimental human cancer[J].Int J Cancer, 2000,15,88(2):260-266.
